(Q30352405)

English

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

author name string

Gale E Smith

1

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

David C Flyer

2

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Ramadevi Raghunandan

3

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Ye Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Ziping Wei

5

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Yingyun Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Eloi Kpamegan

7

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Denise Courbron

8

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Louis F Fries

9

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Gregory M Glenn

10

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

language of work or name

0 references

publication date

26 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

4305-4313

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Pandemic influenza viruses--hoping for the road not taken

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Synthetic generation of influenza vaccine viruses for rapid response to pandemics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

FluBlok, a recombinant hemagglutinin influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Human infection with a novel avian-origin influenza A (H7N9) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.043

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.07.043

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30352405&oldid=1974606517"